Gettinger S - Search Results

1

High SOX2 levels predict better outcome in non-small cell lung carcinomas.

Velcheti V, Schalper K, Yao X, Cheng H, Kocoglu M, Dhodapkar K, Deng Y, Gettinger S, Rimm DL. Velcheti V, et al. Among authors: gettinger s. PLoS One. 2013 Apr 19;8(4):e61427. doi: 10.1371/journal.pone.0061427. Print 2013. PLoS One. 2013. PMID: 23620753 Free PMC article.

2

Targeted therapy in advanced non-small-cell lung cancer.

Gettinger S. Gettinger S. Semin Respir Crit Care Med. 2008 Jun;29(3):291-301. doi: 10.1055/s-2008-1076749. Semin Respir Crit Care Med. 2008. PMID: 18506667 Review.

3

High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.

Anagnostou VK, Bepler G, Syrigos KN, Tanoue L, Gettinger S, Homer RJ, Boffa D, Detterbeck F, Rimm DL. Anagnostou VK, et al. Among authors: gettinger s. Clin Cancer Res. 2009 Jun 15;15(12):4157-64. doi: 10.1158/1078-0432.CCR-09-0099. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509151

4

Management of patients with advanced non-small cell lung cancer: current and emerging options.

Triano LR, Deshpande H, Gettinger SN. Triano LR, et al. Drugs. 2010;70(2):167-79. doi: 10.2165/11532200-000000000-00000. Drugs. 2010. PMID: 20108990 Review.

5

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.

Anagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN. Anagnostou VK, et al. Among authors: gettinger s. BMC Cancer. 2010 May 9;10:186. doi: 10.1186/1471-2407-10-186. BMC Cancer. 2010. PMID: 20459695 Free PMC article.

6

Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.

Anagnostou VK, Dimou AT, Botsis T, Killiam EJ, Gustavson MD, Homer RJ, Boffa D, Zolota V, Dougenis D, Tanoue L, Gettinger SN, Detterbeck FC, Syrigos KN, Bepler G, Rimm DL. Anagnostou VK, et al. Cancer. 2012 Mar 15;118(6):1607-18. doi: 10.1002/cncr.26450. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009766 Free article.

7

A decade of advances in treatment for advanced non-small cell lung cancer.

Gettinger S, Lynch T. Gettinger S, et al. Clin Chest Med. 2011 Dec;32(4):839-51. doi: 10.1016/j.ccm.2011.08.017. Clin Chest Med. 2011. PMID: 22054890 Review.

8

A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.

Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. Johung KL, et al. Among authors: gettinger sn. Clin Cancer Res. 2013 Oct 1;19(19):5523-32. doi: 10.1158/1078-0432.CCR-13-0836. Epub 2013 Jul 29. Clin Cancer Res. 2013. PMID: 23897899

9

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer.

Dhodapkar KM, Gettinger SN, Das R, Zebroski H, Dhodapkar MV. Dhodapkar KM, et al. Oncoimmunology. 2013 Jul 1;2(7):e25205. doi: 10.4161/onci.25205. Epub 2013 Jun 10. Oncoimmunology. 2013. PMID: 24073380 Free PMC article.

10

Programmed death ligand-1 expression in non-small cell lung cancer.

Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL. Velcheti V, et al. Among authors: gettinger sn. Lab Invest. 2014 Jan;94(1):107-16. doi: 10.1038/labinvest.2013.130. Epub 2013 Nov 11. Lab Invest. 2014. PMID: 24217091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters